Clinical trial
A Multiple-Ascending Dose Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of LY3537031 in Overweight and Obese Participants and Healthy Volunteers
NCT06606106 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multiple-Ascending Dose Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of LY3537031 in Overweight and Obese Participants and Healthy Volunteers
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- September 5, 2024
- Completion date
- November 30, 2026
- Enrollment
- 302 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.